Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
Laurie, Scott A., Gupta, Ashish, Chu, Quincy, Lee, Christopher W., Morzycki, Wojciech, Feld, Ronald, Foo, Alison H., Seely, Jean, Goffin, John R., Laberge, Francis, Murray, Nevin, Rao, Sanjay, Nicholas, Garth, Laskin, Janessa, Reiman, Tony, Sauciuc, Delia, Seymour, Lesley
Published in Journal of thoracic oncology (01.11.2011)
Published in Journal of thoracic oncology (01.11.2011)
Get full text
Journal Article
Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group
Buckstein, Rena, Kuruvilla, John, Chua, Neil, Lee, Christina, Macdonald, David A., Al-tourah, Abdulwahab J., Foo, Alison H., Walsh, Wendy, Percy ivy, S., Crump, Michael, Eisenhauer, Elizabeth A.
Published in Leukemia & lymphoma (01.05.2011)
Published in Leukemia & lymphoma (01.05.2011)
Get full text
Journal Article